🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How and when should HRR testing be integrated into prognostic and treatment strategies for mCRPC? This #MensHealthWeek, stay informed on the latest news and research in #prostatecancer with expert highlights from #ASCO25, #EAU25, and #GU25 #MedX ow.ly/nPZr50W6bpk

Why is clear and consistent guidance on HRR testing becoming an increasingly recognised unmet need in #mCRPC? Find out with our visual overview of HRR testing recommendations from selected current guidelines #MensHealthWeek #ProstateCancer ow.ly/aT6650W2rLu

Short on time? Our latest research round-ups on #prostatecancer management are now available on the Medthority Prostate Cancer Nexus. From PARP inhibitors to personalised care, stay up to date on recent developments in prostate cancer care #MedX ow.ly/li9t50W2Eas

Can investigational treatments address unmet needs in mCRPC, and what are the barriers to uptake of clinical practice guidelines? Get answers with expert opinions from Axel S. Merseburger and Neeraj Agarwal, MD, FASCO on the latest in mCRPC management #MedX ow.ly/UCnW50W2El2

#EAACI2025 kicks off today! We’ll be highlighting the latest trial data presented at the conference, coming soon on Medthority. Register now to get closer to the conversations that matter in #immunology and stay up to date with recent developments #MedX ow.ly/N8oV50W39xi

What are the latest updates on potential treatment options for #NMIBC? Gary Steinberg summarizes findings on investigational treatments discussed at #ASCO25 in free, on-demand highlights only on Medthority #MedX #Oncology ow.ly/7MtY50Wa52l

Could earlier genomic testing be the key to better prostate cancer treatment? Gerhardt Attard presents the updates from #ASCO25 you need to know, including a new approach in #mCSPC that can significantly reduce disease progression #MedX #Oncology ow.ly/4Xmb50Wa5eX

What are the physical and psychological impacts of #HS? Watch Joslyn Kirby present an overview of disease burden, plus get the latest insights to help support patients through these challenges with our newly updated HS Learning Zone #MedX ow.ly/LweB50Wa6RG

Earn 1 #CME credit with expert insights on AATD-associated liver disease from #EASL2025. Watch the accredited symposium, led by Rohit Loomba, to get the latest updates on the Pi*ZZ genotype, emerging therapies, and the real patient experience #MedX ow.ly/1ev650Wa6ck

Ahead of #EAN25 starting today, get closer to the expert discussions happening in neurology with this accredited, on-demand symposium on late-onset Pompe disease (#LOPD). Watch now to earn your #CME credit, only on Medthority #MedX #Neurology ow.ly/le7n50Wa714

Are you attending #ISTH25? Keep an eye out for upcoming highlights from this year’s event, on demand with Medthority. In the meantime, catch up with key discussions from last year’s event, including real-world evidence and stroke prevention in AF #MedX ow.ly/kzhv50Wa9Ow

How can treatment strategies for #mCRPC be optimized for patients with varying genomic profiles? Stay up to date with recent advances discussed at #ASCO25 with expert on-demand highlights from Stefanie Zschäbitz #MedX ow.ly/6N3q50WaGf1

Navigate the diagnostic barriers of #CIDP with free resources to help you identify differences in electrodiagnostic and clinical criteria according to CIDP type, plus get updated diagnostic guidelines from EFNS/PNS 2021 on Medthority #MedX ow.ly/zqxE50WfZiK

Are you looking for actionable insights on implementing the latest clinical data into your practice? Register with Medthority now to access free, on-demand resources that are supporting over 85% of our members to improve outcomes for their patients #MedX ow.ly/ovTN50WhjAo

What’s new in #CSU? Visit our newly updated CSU Learning Zone to get clinical insights on optimizing CSU care, with patient case studies presented by Sophia Neisinger, Karsten Weller, and Ana Maria Giménez-Arnau #MedX ow.ly/lFzm50WaBWX

What new data from #EAACICongress could shift how #CSU is diagnosed and treated? Get a summary of the latest updates, from long-term symptom control to persistent care gaps and mental health burden, on-demand with Medthority #MedX #EAACI2025 ow.ly/WEfV50WijUQ

Get closer to the conversations that matter in thrombosis diagnosis and management with expert insights from #ISTH2025. Watch Vicky Mai present study data on the recurrent VTE symptoms you need to look out for #MedX ow.ly/34T350Wj4FR

How can you help guide people with #NMIBC when choosing between bladder removal or a more conservative treatment approach? Stephanie Chisolm, PhD from Bladder Cancer Advocacy Network and Janet Kukreja discuss key recent trial data plus tips on supporting patients #MedX ow.ly/yMK650WiXiw

Don’t miss the chance to hear key discussions on #TK2d from our independent symposium at #EPNS2025. Register now for this upcoming opportunity to earn #CME credit and hear expert guidance on TK2d diagnosis and management, free and on demand #MedX ow.ly/X7kF50WksQU

New study reveals treatment priorities for people with #CIDP. Visit Medthority to read more on the 19 key signs and symptoms identified and how these can help inform CIDP drug development #MedX #Neurology #RareDisease #MedicalNews ow.ly/P65i50Wikt5